As regulators, we have a great opportunity to build on the COVID experience and make sure that we are part of an ecosystem that brings new…
In Conversation
The way our system has developed means that either we all win together, or we all lose together. Collaboration, therefore, is the key to future success
I believe it is high time for Belgium to have price freedom in the OTC medicine market. The current process of getting approval for prices from…
To further uplift [Greece's] positioning [as a clinical trials hub], administrative procedures should be decomplexified to create a more promising environment for collaboration among stakeholders
While Belgium is best known internationally for beer and chocolate, the number one industrial sector in our country is pharma. Our economic impact is sizeable
In the complex era in which we now live, breaking down silos is crucial. Proximity creates opportunity; only when people know and trust each other can…
There is a clear ambition at all levels to facilitate the secondary use of health data [in Belgium]. This is a major trend and I hope…
We need to view healthcare spending as an investment and prioritize the allocation of resources to ensure better health outcomes for all.
In 2023, we face a new digital relations landscape where a customer and a brand more and more rely on personal data exchange and unique communication…
Not only does [Novartis] have a major manufacturing site in Puurs, but we also have probably the largest R&D footprint in the Belgian industry with more…
I am grateful to have had the opportunity to be part of this exceptional team here in Belgium and I am excited by our important work…
George Mitropoulos – Head of Business Development Southeast Europe & Leader for Health Sciences Sector Greece, EY

We believe that evolution can come through fostering ecosystems in the sector since the challenges are often multi-factorial